DE69939559D1 - Methode zur Beschleunigung der Schleimauflöserate - Google Patents

Methode zur Beschleunigung der Schleimauflöserate

Info

Publication number
DE69939559D1
DE69939559D1 DE69939559T DE69939559T DE69939559D1 DE 69939559 D1 DE69939559 D1 DE 69939559D1 DE 69939559 T DE69939559 T DE 69939559T DE 69939559 T DE69939559 T DE 69939559T DE 69939559 D1 DE69939559 D1 DE 69939559D1
Authority
DE
Germany
Prior art keywords
accelerating
rate
mucus dissolution
mucus
dissolution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69939559T
Other languages
English (en)
Inventor
Roderick Hall
Christopher T Poll
Benjamin B Newton
William J A Taylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of DE69939559D1 publication Critical patent/DE69939559D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
DE69939559T 1998-12-22 1999-12-22 Methode zur Beschleunigung der Schleimauflöserate Expired - Fee Related DE69939559D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21891398A 1998-12-22 1998-12-22
US44196699A 1999-11-17 1999-11-17

Publications (1)

Publication Number Publication Date
DE69939559D1 true DE69939559D1 (de) 2008-10-23

Family

ID=26913378

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69912988T Expired - Fee Related DE69912988T2 (de) 1998-12-22 1999-12-22 Verwendung eines serinproteaseinhibitors vom kunitz-typ zur beschleunigung der schleimauflöserate
DE69939559T Expired - Fee Related DE69939559D1 (de) 1998-12-22 1999-12-22 Methode zur Beschleunigung der Schleimauflöserate

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69912988T Expired - Fee Related DE69912988T2 (de) 1998-12-22 1999-12-22 Verwendung eines serinproteaseinhibitors vom kunitz-typ zur beschleunigung der schleimauflöserate

Country Status (13)

Country Link
US (1) US20070086956A1 (de)
EP (2) EP1140150B1 (de)
JP (2) JP3819239B2 (de)
CN (1) CN1229138C (de)
AR (1) AR030257A1 (de)
AT (2) ATE254473T1 (de)
AU (1) AU758832B2 (de)
CA (1) CA2356404C (de)
DE (2) DE69912988T2 (de)
DK (2) DK1374891T3 (de)
ES (2) ES2318075T3 (de)
TW (1) TWI249406B (de)
WO (1) WO2000037099A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7244616B2 (en) 2003-06-27 2007-07-17 Bayer Pharmaceuticals Corporation Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells
CN1332715C (zh) * 2003-09-09 2007-08-22 王继峰 蛋白酶抑制剂在制备预防和治疗肺部疾病的药物中的用途
EP1586587A1 (de) * 2004-04-16 2005-10-19 Exonhit Therapeutics SA Zusammensetzungen und Verfahren zum Nachweis der Angiogenese
GB0411145D0 (en) * 2004-05-19 2004-06-23 Imp College Innovations Ltd Protease inhibitors and their therapeutic applications
CN100408094C (zh) * 2005-08-29 2008-08-06 吉林圣元科技有限责任公司 蛋白酶抑制剂在保护肝细胞功能中的应用
AU2007297691B2 (en) * 2006-09-19 2013-12-19 Discovery Laboratories, Inc. Pulmonary surfactant formulations and methods for promoting mucus clearance
WO2013175007A1 (en) * 2012-05-25 2013-11-28 Inserm Agents for treating cystic fibrosis
JP2016204360A (ja) 2015-02-25 2016-12-08 エー１エム ファーマ エービーＡ１Ｍ Ｐｈａｒｍａ ＡＢ 放射性核種療法における腎臓の保護に用いるためのアルファ−１−ミクログロブリン

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223482A (en) * 1986-11-17 1993-06-29 Scios Nova Inc. Recombinant Alzheimer's protease inhibitory amyloid protein and method of use
US5106833A (en) * 1987-07-23 1992-04-21 Washington University Coagulation inhibitors
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5663143A (en) * 1988-09-02 1997-09-02 Dyax Corp. Engineered human-derived kunitz domains that inhibit human neutrophil elastase
DK0401508T3 (da) * 1989-05-13 1995-05-15 Bayer Ag Proteaseinhibitorer, fremgangsmåde til deres fremstilling samt lægemidler med indhold deraf
DK408089D0 (da) * 1989-08-18 1989-08-18 Novo Nordisk As Proteiner
JP3819931B2 (ja) * 1991-03-01 2006-09-13 ダイアックス コープ． 人体の好中球エラステーゼと人体カテプシンｇの抑制因子
RU2054180C1 (ru) * 1991-08-21 1996-02-10 Жирнов Олег Петрович (н/п) Способ лечения вирусных респираторных инфекций
IL104325A (en) * 1992-01-07 2000-10-31 Novo Nordisk As Variants of human kunitz-type protease inhibitor domain II of tissue factor pathway inhibitor (TFPI) pharmaceutical compositions containing them a DNA construct encoding them their expression vectors a cell containing said DNA constructs and methods for the production of all the above
JPH07509229A (ja) * 1992-07-13 1995-10-12 コルバス・インターナショナル、インコーポレイテッド ウシ膵トリプシン阻害因子から誘導される因子Ｘａの阻害因子
US5436153A (en) * 1992-12-02 1995-07-25 Sprecher; Cindy A. Human amyloid protein precursor homolog and Kunitz-type inhibitor
AU5684594A (en) * 1992-12-02 1994-06-22 Novo Nordisk A/S Novel human amyloid protein precursor homologue and kunitz-type inhibitors
JP2769083B2 (ja) * 1993-02-22 1998-06-25 日清食品株式会社 エラスターゼ阻害活性を有する新規ペプチドおよびその製造方法
US5455338A (en) * 1993-11-05 1995-10-03 Zymogenetics, Inc. DNA encoding novel human kunitz-type inhibitors and methods relating thereto
JP3805785B2 (ja) * 1994-01-11 2006-08-09 ダイアックス コープ． カリクレイン阻害クニッツドメイン蛋白質およびその相同体
US5795954A (en) * 1994-03-04 1998-08-18 Genentech, Inc. Factor VIIa inhibitors from Kunitz domain proteins
US5786328A (en) * 1995-06-05 1998-07-28 Genentech, Inc. Use of kunitz type plasma kallikrein inhibitors
EP0758682B1 (de) * 1995-07-24 2004-05-12 Mitsubishi Chemical Corporation Inhibitor des Hepatozytwachstumsfaktoraktivators
US5736364A (en) * 1995-12-04 1998-04-07 Genentech, Inc. Factor viia inhibitors
WO1997033996A2 (en) * 1996-03-11 1997-09-18 Bayer Corporation Human bikunin
US20070140979A1 (en) * 1998-12-22 2007-06-21 Bayer Aktiengesellschaft Method for accelerating the rate of mucociliary clearance

Also Published As

Publication number Publication date
DK1140150T3 (da) 2004-03-22
DE69912988D1 (de) 2003-12-24
ATE254473T1 (de) 2003-12-15
TWI249406B (en) 2006-02-21
ES2209542T3 (es) 2004-06-16
AU758832B2 (en) 2003-04-03
ATE407694T1 (de) 2008-09-15
JP2006232810A (ja) 2006-09-07
CA2356404C (en) 2010-03-30
EP1140150B1 (de) 2003-11-19
CN1334743A (zh) 2002-02-06
JP2002532558A (ja) 2002-10-02
JP3819239B2 (ja) 2006-09-06
EP1374891A1 (de) 2004-01-02
DE69912988T2 (de) 2004-11-11
DK1374891T3 (da) 2009-01-26
AU1987800A (en) 2000-07-12
CN1229138C (zh) 2005-11-30
CA2356404A1 (en) 2000-06-29
WO2000037099A2 (en) 2000-06-29
WO2000037099A3 (en) 2000-10-26
US20070086956A1 (en) 2007-04-19
EP1374891B1 (de) 2008-09-10
EP1140150A2 (de) 2001-10-10
AR030257A1 (es) 2003-08-20
ES2318075T3 (es) 2009-05-01

Similar Documents

Publication Publication Date Title
ATE278330T1 (de) Vefahren zur verbesserung der süssefreigabe von sucralose
ATE427102T1 (de) Verfahren zur festkírperkristallisierung
DE60208794D1 (de) 4'-substituierte nukleoside zur behandlung von hepatitis-c-virus-vermittelten erkrankungen
NO20003530D0 (no) Vedvarende frigivelsessammensetning, metode for dens produksjon og anvendelse derav
DE69510611T2 (de) Methode zur Aufbringung geschmolzener, mit Feuchtigkeit härtbarer Organosiloxan-Gemische
IT1315269B1 (it) Metodo per la preparazione di 5-cianoftalide
ATE344661T1 (de) Rar-gamma selektive retinoid-agonisten zur behandlung von emphysemen
DE59907055D1 (de) Verfahren zur herstellung von tetrachlorkohlenstoffarmen phosgen
DE69939559D1 (de) Methode zur Beschleunigung der Schleimauflöserate
DE69521528T2 (de) Methode zur überwachung der entfernung von schlacken
DE59902618D1 (de) Verfahren zur Herstellung von Arylhydrazinen
DE69922786D1 (de) Methode zur behandlung der chronischen obstruktiven bronchopneumopathie
DK1061955T3 (da) Polynukleotidsammensætning, fremstillingsmetode og anvendelse deraf
DE69808300T2 (de) Nitrierungsverfahren zur herstellung von diphenylethern
DK0981950T3 (da) Fremgangsm,åde til formering af phyllocactus
DE60004931D1 (de) Kontinuierliches Verfahren zur Herstellung von 3,5,5-Trimethylcyclohexa-3-en-1-on(beta-Isophoron)
DE50000074D1 (de) Verfahren zur Herstellung von halogenierten 1,2-Disilaethanen
DE59903233D1 (de) Verfahren zur Beeinflussung der Übertragungsrate
DE10197040T1 (de) Verfahren zur Herstellung von Diarylcarbonaten
DE60014832D1 (de) Verfahren zur Leistungsabstimmung des Kuvertiersystems während der Laufzeit
NO20006383L (no) Fremgangsmåte for behandling
DK0930297T3 (da) Fremgangsmåde til fremstilling af naphtyridoner og mellemprodukter
DE60002166D1 (de) Verfahren zur Acylierung von Naphthylethern
AP2005003432A0 (en) Novel method of treatment.
DE59903806D1 (de) Verfahren zur Herstellung von sekundären bzw. tertiären 2-Methyl-1,5-pentandiaminen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee